论文部分内容阅读
外资在我国生物医药领域大肆“圈地”,有关部门应及时出台应对之策《瞭望》新闻周刊从多种渠道获悉,一些跨国资本正在我国生物医药领域展开了一场新药“圈地运动”,他们通过合作、收购,兼并等合法的资本运作手段,试图尽量获取我国那些只差一步就将成熟的科研成果。而我国目前对高科技企业虽然有风险投资机制。但在企业发展壮大过程中却缺乏产业投资机制,导致很多科研活动是“为他人做嫁衣”,成果最后落入外资“腰包”。
Foreign investment in the field of biomedicine wantonly “enclosure”, the relevant departments should promptly issued countermeasures “Outlook” Newsweek learned from many sources, some transnational capital is in the field of biomedicine in our country launched a new drug “enclosure movement” Through legal means of capital operation such as cooperation, acquisitions and mergers, they try to get as far as possible the achievements of China’s scientific research that are only one step behind. At present, China has a risk investment mechanism for high-tech enterprises. However, in the course of business development and growth, there is a lack of industrial investment mechanism, resulting in many scientific and technological activities as “doing wedding dress for others” and eventually falling into the “pockets” of foreign investment.